More on anticardiolipin and anti-beta2 glycoprotein I in systemic sclerosis.
作者信息
Antonioli C M, Danieli E, Airò P, Cattaneo R, Tincani A
出版信息
Ann Rheum Dis. 2003 Jun;62(6):589-90. doi: 10.1136/ard.62.6.589.
Abstract
摘要
相似文献
1
More on anticardiolipin and anti-beta2 glycoprotein I in systemic sclerosis.系统性硬化症中抗心磷脂和抗β2糖蛋白I的更多研究
Ann Rheum Dis. 2003 Jun;62(6):589-90. doi: 10.1136/ard.62.6.589.
2
Antibodies to beta2 glycoprotein I and cardiolipin in SSc.系统性硬化症中抗β2糖蛋白I和抗心磷脂抗体
Ann Rheum Dis. 2002 Feb;61(2):183-4. doi: 10.1136/ard.61.2.183-a.
3
4
Serum anti-beta2-glycoprotein-I and anticardiolipin antibodies during thrombosis in systemic lupus erythematosus patients.系统性红斑狼疮患者血栓形成过程中的血清抗β2-糖蛋白-I和抗心磷脂抗体
Am J Med. 1999 Apr;106(4):417-23. doi: 10.1016/s0002-9343(99)00053-4.
5
Anticardiolipin and anti-beta2 glycoprotein I antibody concentrations in patients with type 2 diabetes mellitus.2型糖尿病患者体内抗心磷脂抗体和抗β2糖蛋白I抗体的浓度
Diabetes Res Clin Pract. 2005 Jun;68(3):181-7. doi: 10.1016/j.diabres.2004.09.005.
6
Measurement of anticardiolipin antibodies by ELISA using beta 2-glycoprotein I (beta 2-GPI) in systemic sclerosis.在系统性硬化症中使用β2-糖蛋白I（β2-GPI）通过酶联免疫吸附测定法检测抗心磷脂抗体
Clin Exp Immunol. 1996 Sep;105(3):475-9. doi: 10.1046/j.1365-2249.1996.d01-774.x.
7
The reactivity of paired plasma and serum samples are comparable in the anticardiolipin and anti-beta2-glycoprotein-1 ELISAs.
J Thromb Haemost. 2006 Jan;4(1):265-7. doi: 10.1111/j.1538-7836.2005.01721.x.
8
Anti-beta2-glycoprotein I antibodies in women with recurrent spontaneous abortion, unexplained fetal death, and antiphospholipid syndrome.复发性自然流产、不明原因胎儿死亡及抗磷脂综合征女性体内的抗β2-糖蛋白I抗体
Am J Obstet Gynecol. 1999 Sep;181(3):642-8. doi: 10.1016/s0002-9378(99)70507-7.
9
10
Prevalence and clinical significance of anticardiolipin and anti-beta2-glycoprotein-I antibodies in patients with non-Hodgkin's lymphoma.非霍奇金淋巴瘤患者中抗心磷脂抗体和抗β2糖蛋白I抗体的患病率及临床意义
Eur J Haematol. 2002 Feb;68(2):84-90. doi: 10.1034/j.1600-0609.2002.01526.x.
引用本文的文献
1
Prevalence and Clinical Associations of Antiphospholipid Antibodies in Systemic Sclerosis: New Data From a French Cross-Sectional Study, Systematic Review, and Meta-Analysis.系统性硬化症中抗磷脂抗体的流行情况及其临床相关性：一项来自法国横断面研究、系统评价和荟萃分析的新数据。
Front Immunol. 2018 Nov 2;9:2457. doi: 10.3389/fimmu.2018.02457. eCollection 2018.
2
[Critical limb ischemia in systemic sclerosis].[系统性硬化症中的严重肢体缺血]
Z Rheumatol. 2012 Jun;71(4):261-9. doi: 10.1007/s00393-011-0914-3.
3
Systemic sclerosis sine scleroderma associated with antiphospholipid syndrome.系统性硬皮病不伴硬皮病相关的抗磷脂综合征。
Rheumatol Int. 2012 Oct;32(10):3265-8. doi: 10.1007/s00296-010-1482-6. Epub 2010 Apr 9.
4
Clinical significance of antiphospholipid antibodies in Indian scleroderma patients.抗磷脂抗体在印度硬皮病患者中的临床意义。
Rheumatol Int. 2009 Dec;30(2):277-9. doi: 10.1007/s00296-009-1107-0.
5
Independent association of anti-beta(2)-glycoprotein I antibodies with macrovascular disease and mortality in scleroderma patients.抗β2糖蛋白I抗体与硬皮病患者大血管疾病和死亡率的独立关联。
Arthritis Rheum. 2009 Aug;60(8):2480-9. doi: 10.1002/art.24684.
6
Autoantibodies in systemic sclerosis (scleroderma): clues for clinical evaluation, prognosis and pathogenesis.系统性硬化症（硬皮病）中的自身抗体：临床评估、预后及发病机制的线索
Wien Med Wochenschr. 2008;158(1-2):19-28. doi: 10.1007/s10354-007-0451-5.
7
Antibodies in scleroderma: direct pathogenicity and phenotypic associations.硬皮病中的抗体：直接致病性及表型关联
Curr Rheumatol Rep. 2004 Apr;6(2):156-63. doi: 10.1007/s11926-004-0061-9.
Zotero 插件